Table 2 Clinicopathological characteristics of NSCLC
From: Mutation analysis of Rad18 in human cancer cell lines and non small cell lung cancer tissues
| Â | WT (n = 12) | SNP (n = 20) | Â |
|---|---|---|---|
| Â | Â | Â | N.S. |
Age (years, mean ± SD) | 70.6 ± 8.2 | 70.0 ± 8.8 |  |
| Â | Â | Â | N.S. |
Sex | Â | Â | Â |
   Male | 9 | 12 |  |
   Female | 3 | 8 |  |
| Â | Â | Â | N.S. |
Histological type | Â | Â | Â |
   Squamous cell carcinoma | 7 | 3 |  |
   Adenocarcinoma | 3 | 14 |  |
   Others | 2 | 3 |  |
| Â | Â | Â | N.S. |
T stage | Â | Â | Â |
   T1 | 4 | 13 |  |
   T2 | 7 | 7 |  |
   T3 | 1 | 0 |  |
| Â | Â | Â | N.S. |
Lymph node metastasis | Â | Â | Â |
   Positive | 2 | 4 |  |
   Negative | 10 | 16 |  |
| Â | Â | Â | N.S. |
pStage | Â | Â | Â |
   IA | 4 | 11 |  |
   IB | 3 | 5 |  |
   IIA | 0 | 2 |  |
   IIB | 5 | 2 |  |